Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802659 · ClinicalTrials.gov registry record · NA
A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00802659 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 2 participants.
The verdict
NCT00802659, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study will evaluate pain control and quality of life in patients with paraspinal metastases, who have receive previous radiation therapy to these lesions, using single dose stereotactic radiotherapy.
Interventions
- RADIATION Stereotactic radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00802659
The ClinicalTrials.gov registry entry for NCT00802659 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic radiotherapy is the first listed.
NCT00802659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00802659 about?
NCT00802659 is a clinical study titled "A Phase I/II Dose Escalation Study Using Extracranial Stereotactic Radiosurgery to Control Pain". This study will evaluate pain control and quality of life in patients with paraspinal metastases, who have receive previous radiation therapy to these lesions, using single dose stereotactic radiotherapy.
What is the current status of trial NCT00802659?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2008-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00802659?
The interventions under investigation include: Stereotactic radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT00802659?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.